Journal of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-03-28 ms9000001809561507 来自黑龙江省

请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-12 ms9000000073552661 来自天津

3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜

2 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-12 ms1000001693455825 来自贵州省

偏重的研究方向：临床
经验分享：8天拒稿，真快也是个好事

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-13 1762000651m 来自湖南省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：cancer therapy;肿瘤
经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published#期刊论坛# #Journal of translational medicine#

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-01-29 ms4000001619259847 来自广东省

23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。
想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。

26 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-03 ms8000000910900972 来自广东省

偏重的研究方向：肿瘤
经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review

11 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-08 ms1000001693455825 来自贵州省

偏重的研究方向：临床
经验分享：这个杂志真的慢。还在NS

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2024-04-07 ms3000001519379089 来自广东省

偏重的研究方向：肿瘤
经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2023-09-24 ms1000001178031157 来自浙江省

审稿速度:3.0
偏重的研究方向：转化医学
经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。

73 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195787, encodeId=a2092195e87ab, content=请问从Editor Assigned到Reviewers assigned得几天啊，会发邮件通知吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36866541160, createdName=ms9000001809561507, createdTime=Thu Mar 28 08:02:00 CST 2024, time=2024-03-28, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2198205, encodeId=6d292198205a7, content=3.28提交 3.29 editor assigned 4.7editor assigned 现在还是分配编辑，啥情况啊呜呜呜 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1998589647, createdName=ms9000000073552661, createdTime=Fri Apr 12 20:12:02 CST 2024, time=2024-04-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198196, encodeId=54902198196f4, content=偏重的研究方向：临床 经验分享：8天拒稿，真快也是个好事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Fri Apr 12 19:04:58 CST 2024, time=2024-04-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2198242, encodeId=2819219824206, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：cancer therapy;肿瘤 经验分享：2023.11.22 new submission 11.23-12.29 editors assigned 中途写了大概3/4个催稿信，都是很官方的回复，还有就是大概是人手不够的意思吧，找不到处理手稿的编辑。 12.29-2024.01.13 review assigned 并给出了一审建议，major revision。其实应该算小修，就两个评审，一个要求补过表达，补流式，说introduction 内容介绍写的不够深入。另一个评审感觉不是领域内的，要求补充一些绿色材料和纳米银之类的内容进入，就和研究很不相关，我在讨论部分添加了几篇引文。 01.14-02.04 补实验，润色文章，并返修。 02.04-02-13 new submission 02-13-03-19 reviews assigned 看到这里，大家也发现二审居然用了快40天。于是，写了两次催稿信，第二次是3.18还是19写的去了，给出的回复是只找到一个审稿人，另外一个找不到了，因为时间也拖我太久了，然后编辑助理说反馈到编辑部，问下编辑部能不能根据这个审稿人的的意见给出是否接受。 3.20 final decision accepted 3.23 eproof 3.27 publications agreement and invoice 4.8 bank transfer 4.11 published<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> #Journal of translational medicine#, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/20/dba75bfefffb6d1db21a417ee0ead30e.jpg, createdBy=5ead2146617, createdName=1762000651m, createdTime=Sat Apr 13 01:23:25 CST 2024, time=2024-04-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2184627, encodeId=5d2c218462eb9, content=23年12.13submitted，12.21变Reviewers Assigned，直到现在一直没动静。 想问问编辑一般一次联系多少个审稿人，是不是一个多月都找不到审稿人就要直接拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19de5689350, createdName=ms4000001619259847, createdTime=Mon Jan 29 12:32:12 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196858, encodeId=e4f62196858c7, content=偏重的研究方向：肿瘤 经验分享：几乎每天都去看哈哈，记录一下，接心软的审稿人🙏🏻 3.16 New Submission 3.19 Editors Assigned 3.21 Reviewers Assigned 4.2 Reviewers Assigned 4.3 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fb79153115, createdName=ms8000000910900972, createdTime=Wed Apr 03 20:27:18 CST 2024, time=2024-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197369, encodeId=34f9219e369f3, content=偏重的研究方向：临床 经验分享：这个杂志真的慢。还在NS, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0cc9246921, createdName=ms1000001693455825, createdTime=Mon Apr 08 11:10:31 CST 2024, time=2024-04-08, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2197241, encodeId=89d1219e2418d, content=偏重的研究方向：肿瘤 经验分享：离谱，4月6投已经3793号了，这也太多稿件了。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec9e8516334, createdName=ms3000001519379089, createdTime=Sun Apr 07 13:32:56 CST 2024, time=2024-04-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159445, encodeId=d02d21594454c, content=审稿速度:3.0 偏重的研究方向：转化医学 经验分享：5-18 Submission 大概一周送审 7-14 Reviews completed 8-2 催稿 8-10 Minor revise 8-14 Resubmit 9-2 Reviews completed 9-23 Accept 编辑和审稿人都很棒，回复邮件很及时，对国人友好，总体投稿体验非常舒适，值得尝试的杂志，祝大家投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=400a5417564, createdName=ms1000001178031157, createdTime=Sun Sep 24 15:48:56 CST 2023, time=2023-09-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161004, encodeId=8f5e216100472, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：2023-8-3submit 2023-8-10major revision 2023-9-18revise submit（本来一个月，延期了一周） 2023-10-3accept 很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c66415333, createdName=ms6000000296334309, createdTime=Thu Oct 05 09:49:14 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省)]

2023-10-05 ms6000000296334309 来自广东省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：2023-8-3submit
2023-8-10major revision
2023-9-18revise submit（本来一个月，延期了一周）
2023-10-3accept
很快！一开始状态变成了editor assigned我以为重新分配编辑，结果是一审意见已经回到编辑，一周给major revision，这速度还有谁

79 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务